Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

28.19

+1.32 (4.91%)

At close: Feb 24, 2026, 4:00 PM EST

28.75

+0.56 (1.99%)

After-hours: Feb 24, 2026, 7:38 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Rare Neurological Diseases	714.73M	582.02M	437.86M	305.44M	159.74M
Rare Neurological Diseases Growth	22.80%	32.93%	43.35%	91.21%	2564.59%
Total	714.73M	582.02M	437.86M	305.44M	159.74M
Total Growth	22.80%	32.93%	43.35%	91.21%	2564.59%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States (U.S.)	714.73M	582.02M	437.86M	305.44M	159.74M
United States (U.S.) Growth	22.80%	32.93%	43.35%	91.21%	2564.59%
Total	714.73M	582.02M	437.86M	305.44M	159.74M
Total Growth	22.80%	32.93%	43.35%	91.21%	2564.59%

Source: S&P Global Market Intelligence.